Guidance

UK NSC disease, clinical effectiveness and cost effectiveness modelling

This document outlines the UK National Screening Committee바카라 사이트™s systematic approach to the use of decision analytic modelling as part of the evidence review process

Documents

Details

This document supports the following recommendation made by the 4 UK chief medical officers (CMOs) for the expanded remit of the UK National Screening Committee (UK NSC) following the :

It is suggested that the secretariat for the new UK NSC expands the evidence review process to include potential targeted screening programmes and should consider as a minimum:

  • any additional steps that need to be factored in for proposals for targeted screening programmes
  • the process for working with the National institute for Health and Care Excellence (NICE) and the Scottish Intercollegiate Guidelines Network (SIGN) on clinical care guidelines
  • any additional steps for evaluating a stratified screening approach for either population or targeted screening programmes

Email uknsc@dhsc.gov.uk if you have any queries about this publication, making sure you include its full title.

Updates to this page

Published 29 September 2022

Sign up for emails or print this page